Not yet recruiting

4

336

RoW

Danning Tablet, Biliflow (NPN 80073325, manufactured by Shanghai Hutchison Pharmaceuticals Limited)

Eastern Hepatobiliary Surgery Hospital

Polyps Gallbladder

08/24

11/24

Not yet recruiting

3

165

RoW

TQB3454 tablets, TQB3454 tablets matching placebo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Biliary Carcinoma

12/26

12/26

Recruiting

1/2

103

RoW

TQB2102 for injection

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Biliary Tract Cancer

05/25

12/25

Recruiting

4

102

RoW

Esketamine hydrochloride injection, 0.9% sodium chloride injection

Zhang XIao Mei

Heart Diseases, Heart Valve Diseases

05/25

05/25

Recruiting

4

400

RoW

amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution

Chengdu Qingshan Likang Pharmaceutical Co., Ltd

End Stage Renal Disease (ESRD)

06/25

06/25

Recruiting

4

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

Completed

3

163

RoW

Lotilaner, TP-03, S-Misoxam, Vehicle Control

LianBio LLC

Blepharitis

09/23

04/24

Recruiting

3

450

Europe, US, RoW

LY3650150, Placebo, Standard therapy for INCS

Eli Lilly and Company

Perennial Allergic Rhinitis (PAR)

Recruiting

3

1200

Europe, Canada, Japan, US, RoW

Remternetug, LY3372993, Placebo

Eli Lilly and Company

Alzheimer's Disease

04/29

10/30

Recruiting

3

400

Europe, Canada, Japan, US, RoW

tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil

Seagen Inc., Merck Sharp & Dohme LLC

Colorectal Neoplasms

08/25

04/28

Recruiting

2/3

230

Canada, US

MN-166, ibudilast, placebo

MediciNova

Amyotrophic Lateral Sclerosis

12/25

12/26

Recruiting

2a

60

RoW

50561 high dose, 50561 low dose, Placebo

Beijing Joekai Biotechnology LLC

Alzheimer's Disease

05/24

06/24

Terminated

2

8

RoW

efgartigimod IV, placebo

argenx, Zai Lab Pty. Ltd.

Membranous Nephropathy

08/24

08/24

Recruiting

2

320

RoW

SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan

Shanghai Pharmaceuticals Holding Co., Ltd

Diabetic Kidney Disease

Not yet recruiting

2

168

RoW

TQH2722 injection, TQH2722 Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Seasonal Allergic Rhinitis

06/25

08/25

Suspended

2

279

Europe, US, RoW

zetomipzomib, KZR-616, placebo, matching placebo

Kezar Life Sciences, Inc.

Lupus Nephritis

05/26

07/26

Recruiting

1

64

Europe, Canada

Multiple ascending doses of QRL-201, Multiple ascending doses of Placebo, QRL-201, Placebo

QurAlis Corporation

Amyotrophic Lateral Sclerosis

08/26

08/26

Terminated

N/A

1706

RoW

SpO2 directed oxygen therapy

Wuhan Union Hospital, China, Wu Jieping Medical Foundation

Critical Illness

05/22

05/22

Completed

N/A

31

RoW

Blood collection

Société des Produits Nestlé (SPN), Peking Union Medical College Hospital

Healthy, PreDiabetes, Adult, Asian

03/23

03/23

Recruiting

N/A

250

RoW

Nutren Diabetes, Fresubin Diabetes

Société des Produits Nestlé (SPN), Nestle Health Science

Diabetes Mellitus

12/24

06/25

Recruiting

N/A

108

RoW

Samples materials of basic taste stimuli and enteral nutrition preparations

Peking Union Medical College Hospital

Cancer- and Cancer Treatment-Related Conditions, Stroke

06/24

12/24

Active, not recruiting

N/A

11737

US

Tulane University, National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS)

Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Hypertension

11/29

11/29

Recruiting

N/A

3838

RoW

Thrombus aspiration, PCI Alone

Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital

ST-segment Elevation Myocardial Infarction (STEMI)

08/25

02/26

Recruiting

N/A

90000

RoW

Guangdong Provincial People's Hospital

Chronic Kidney Disease

12/26

12/28

Completed

3

242

RoW

NL003, HGF plasmid, pCK-HGF-X7, Normal Saline, Placebo

Beijing Northland Biotech. Co., Ltd.

Arterial Occlusive Disease, Ischemia, Ulcers, Peripheral Vascular Disease

12/23

12/23

Recruiting

3

688

RoW

Radical colectomy, HIPEC, Systemic chemotherapy

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University

Colorectal Cancer

04/24

04/26

Completed

3

206

RoW

Daridorexant, Placebo

Jiangsu Simcere Pharmaceutical Co., Ltd.

Insomnia Disorder

04/24

05/24

Recruiting

2

180

RoW

TQH3821 tablets 200 mg, TQH3821 tablets matching placebo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Rheumatoid Arthritis

06/24

12/24

Not yet recruiting

2

55

RoW

ADC Combined With Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2

Second Affiliated Hospital of Soochow University

Carcinoma, Solid Tumor

10/24

04/25

Recruiting

1/2

80

RoW

Sulfasalazine, Ambrisentan, Sulfasalazine's placebo, Ambrisentan's placebo

RenJi Hospital

Pulmonary Arterial Hypertension

12/21

10/22

Not yet recruiting

N/A

2700

RoW

EXCROSSAL

JW Medical Systems Ltd

Coronary Artery Disease

12/21

12/25

Recruiting

N/A

65

US

Xiangya Hospital of Central South University

Hydrocephalus

12/22

12/22

Terminated

N/A

3

RoW

Spinal Cord Stimulation

Huashan Hospital

Progressive Supranuclear Palsy, Spinal Cord Stimulation

12/23

12/23

Not yet recruiting

N/A

500

RoW

Octreotide microspheres

Qilu Hospital of Shandong University

Neuroendocrine Tumors

11/27

05/28

Recruiting

N/A

128

RoW

Calorie-restricted diet (CRD), Time-restricted eating (TRE)

Xiaoyan Shi, Soochow University

Childhood Obesity

12/25

12/26

Active, not recruiting

N/A

51

RoW

MitraClip procedure

Abbott Medical Devices

Mitral Regurgitation

05/24

05/25

Recruiting

N/A

1017

US, RoW

Infuse™ Bone Graft (Infuse™), Intervertebral body fusion device and Medtronic posterior Fixation Systems

Medtronic Spinal and Biologics

Degenerative Disease of the Lumbosacral Spine

04/26

04/28

Recruiting

N/A

1332

RoW

The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours

Zhengzhou Yuan

Stroke, Acute, Endovascular Therapy

11/25

04/26

Recruiting

N/A

168

US, RoW

Extend LymphAdenectomy

Second Affiliated Hospital, School of Medicine, Zhejiang University

Intrahepatic Cholangiocarcinoma

12/27

12/27

Terminated

2

24

US, RoW

Sirolimus 0.2%, Rapamune, rapamycin, mTOR inhibitor, Sirolimus 0.4%, Placebo ointment, Placebo

Aucta Pharmaceuticals, Inc

Angiofibroma of Face, Tuberous Sclerosis

03/23

03/23

Recruiting

3

480

RoW

Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Hepatocellular Carcinoma

08/24

12/26

Recruiting

3

108

RoW

Envafolimab

Sir Run Run Shaw Hospital

Rectal Cancer

04/25

12/28

Recruiting

2

30

RoW

Adebrelimab, SHR-1316, Oxaliplatin, Capecitabine, Short-course Radiation, Biopsy

Sir Run Run Shaw Hospital

Rectal Adenocarcinoma

01/25

12/27

Recruiting

1

10

RoW

hiHep bioartificial liver therapy

Sir Run Run Shaw Hospital, Hexaell Biotech Co., Ltd

Hepatoma Resectable

11/21

12/21

Recruiting

1

20

RoW

iNeo-Vac-R01

Sir Run Run Shaw Hospital, Hangzhou Neoantigen Therapeutics Co., Ltd.

Digestive System Neoplasms

08/27

12/27

Recruiting

1

20

RoW

iNeo-Vac-R01 in combination with standard adjuvant therapy

Sir Run Run Shaw Hospital, Hangzhou Neoantigen Therapeutics Co., Ltd.

Digestive System Neoplasms

08/27

12/27

Recruiting

N/A

570

RoW

Stent-based Diverting Technique

Sir Run Run Shaw Hospital

Rectal Neoplasms

12/24

06/25

Active, not recruiting

2

103

RoW

Encorafenib, Braftovi®, PF-07263896, W0090, LGX818, ONO-7702, Cetuximab, Erbitux®, C225, FOLFIRI, Folinic acid + Fluorouracil + Irinotecan

Pierre Fabre Medicament, Merck KGaA, Darmstadt, Germany

BRAF V600E, Metastatic Colorectal Cancer

12/23

01/25

Active, not recruiting

N/A

297

RoW

lenvatinib, lenvatinib treatment, TACE, transcatheter arterial chemoembolization

Fudan University

Hepatocellular Carcinoma

06/22

06/23